Sign inSubscribe

target directory

a lci oct imaging probe esophageal biopsy clinical trial intelligence

Trials are included when the normalized target field matches this target directory. Full protocol, result, eligibility and IP analysis is available inside the premium workspace.

Validated reports

1

Directory type

target

Association rule

normalized field

NCT04392167
Source recordAI-normalized

Advanced Angle-Resolved Low Coherence Interferometry (a/LCI) Systems for Improved Clinical Utility: An a/LCI-Optical Coherence Tomography (OCT) Pilot Study

This study will test a newly developed dual modality probe, including optical coherence tomography (OCT) and angle-resolved low-coherence interferometry (a/LCI), in the human esophagus to determine 1) whether adequate tissue contact can be attained by the probe to acquire high quality images, and 2) to identify if these images can discern whether the imaged tissue is squamous or Barrett's Esophagus (BE) epithelium. This pilot study will test the operating characteristics of the probe and collect data for further optimization of the a/LCI-OCT device.

AI analysis

Indication: Barrett Esophagus

Modality: medical device

Target: a/LCI-OCT imaging probe, esophageal biopsy

Sponsor: Duke University

Source URL: ClinicalTrials.gov

Source updated: Nov 28, 2023

Ingested: Jun 09, 2026

Model: trialsignal-ai-v1

Validation: validated

Matched by target_normalized: a/LCI-OCT imaging probe, esophageal biopsy

View original source fields

Condition raw: Barrett Esophagus

Condition normalized: Barrett Esophagus

Modality raw: medical device

Modality normalized: medical device

Target raw: a/LCI-OCT imaging probe, esophageal biopsy

Target normalized: a/LCI-OCT imaging probe, esophageal biopsy

Open report